Cover Image
市場調查報告書

久光製藥的產品平台分析

Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 320382
出版日期 內容資訊 英文 29 Pages
訂單完成後即時交付
價格
Back to Top
久光製藥的產品平台分析 Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2015
出版日期: 2015年09月23日 內容資訊: 英文 29 Pages
簡介

正在製造、銷售抗發炎·止痛用粘貼藥,抗真菌藥物,止痛藥,皮膚用藥物,化妝品,醫藥部外品,呼吸系統藥物等醫藥品。品牌名有SALONPAS、ByeBye-FEVER、MOHRUS等,給藥型態有貼片,凝膠,乳液,化妝水。

本報告提供久光製藥的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

久光製藥的基本資料

  • 久光製藥概要
  • 主要資訊
  • 企業資料

久光製藥:R&D概要

  • 主要的治療範圍

久光製藥:開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

久光製藥:開發中產品概況

  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

久光製藥:藥物簡介

  • dextroamphetamine
  • HP-3060
  • ropinirole hydrochloride
  • HP-3070

久光製藥:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

久光製藥:最新的開發平台資訊

久光製藥:開發暫停中的產品

久光製藥:開發中止的開發中產品

久光製藥:總公司和子公司的所在地

  • 總公司
  • 分公司及子公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07594CDB

Summary

Global Markets Direct's, 'Hisamitsu Pharmaceutical Co., Inc. - Product Pipeline Review - 2015', provides an overview of the Hisamitsu Pharmaceutical Co., Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Hisamitsu Pharmaceutical Co., Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Hisamitsu Pharmaceutical Co., Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Hisamitsu Pharmaceutical Co., Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Hisamitsu Pharmaceutical Co., Inc.'s pipeline products

Reasons to buy

  • Evaluate Hisamitsu Pharmaceutical Co., Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Hisamitsu Pharmaceutical Co., Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Hisamitsu Pharmaceutical Co., Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Hisamitsu Pharmaceutical Co., Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Hisamitsu Pharmaceutical Co., Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Hisamitsu Pharmaceutical Co., Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Hisamitsu Pharmaceutical Co., Inc. Snapshot
    • Hisamitsu Pharmaceutical Co., Inc. Overview
    • Key Information
    • Key Facts
  • Hisamitsu Pharmaceutical Co., Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products Glance
    • Hisamitsu Pharmaceutical Co., Inc. - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • Hisamitsu Pharmaceutical Co., Inc. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Hisamitsu Pharmaceutical Co., Inc. - Drug Profiles
    • HP-3060
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HP-3150
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • ropinirole hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dextroamphetamine
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • HP-3070
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Analysis
    • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Target
    • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Route of Administration
    • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Molecule Type
    • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Mechanism of Action
  • Hisamitsu Pharmaceutical Co., Inc. - Recent Pipeline Updates
  • Hisamitsu Pharmaceutical Co., Inc. - Discontinued Pipeline Products
    • Discontinued Pipeline Product Profiles
      • ketoprofen patch
  • Hisamitsu Pharmaceutical Co., Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Hisamitsu Pharmaceutical Co., Inc., Key Information
  • Hisamitsu Pharmaceutical Co., Inc., Key Facts
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Indication, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Stage of Development, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Monotherapy Products in Pipeline, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Partnered Products in Pipeline, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Partnered Products/ Combination Treatment Modalities, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Phase III, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Phase II, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Phase I, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Target, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Route of Administration, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Molecule Type, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Mechanism of Action, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Recent Pipeline Updates, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Discontinued Pipeline Products, 2015
  • Hisamitsu Pharmaceutical Co., Inc., Other Locations
  • Hisamitsu Pharmaceutical Co., Inc., Subsidiaries

List of Figures

  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Top 10 Indication, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Stage of Development, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Monotherapy Products in Pipeline, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Top 10 Target, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Top 10 Route of Administration, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline by Top 10 Molecule Type, 2015
  • Hisamitsu Pharmaceutical Co., Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top